66993-142 : Aliskiren 300 mg Oral Tablet, Film Coated


NDC66993-142
Labeler: Prasco Laboratories
Product Type: Human Prescription Drug
Drug Name:  Aliskiren
Dosage Form: Oral Tablet, Film Coated
Application #: NDA021985
Rev. Date: 


Appearance:


Markings: NVR;IU
Shapes:  Oval
Colors:  Red
Size (mm): 18
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 66993-142-30: 30 TABLET, FILM COATED IN 1 BOTTLE (66993‑142‑30)

Active Ingredients:

  • Aliskiren Hemifumarate

Dosage Strength:

  • 300 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Crospovidone (15 Mpa.s At 5%)
  • Hypromelloses
  • Ferric Oxide Red
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycol, Unspecified
  • Talc
  • Titanium Dioxide
  • Ferrosoferric Oxide /

Pharmaceutical Classes:

  • Renin Inhibitor [EPC]
  • Renin Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 66993-141 Aliskiren 150 mg Oral Tablet, Film Coated by Prasco Laboratories
  • 49884-424 Aliskiren 150 mg Oral Tablet, Film Coated by Par Pharmaceutical, Inc.
  • 49884-425 Aliskiren 300 mg Oral Tablet, Film Coated by Par Pharmaceutical, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 66993-142 QR Code

< Prev: 66993-141Next: 66993-160 >

Related Discussions:

Aliskiren and weight loss
Has anyone experienced increased weight loss when taking this medication, or abdominal pain ## Aliskiren is a direct ren... 5 replies
aliskiren/weight loss
Can aliskiren cause weight loss ## Aliskiren is a direct renin inhibitor used to treat Hypertension. It is not known to ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.